Merck & Co.: elects Paul J. Diaz to board

What happened The filing says Merck & Co., Inc. announced the election of Paul J. Diaz to the company’s board of directors, effective Nov 1, 2026. The board appointed Mr. Diaz as a member of the Audit Committee and the Research Committee. The filing references a press release issued Oct 13, 2026 and states Mr. Diaz will receive compensation as a non-employee director in accordance with the company’s non-employee director compensation practices described in the definitive proxy on Schedule 14A filed Apr 8, 2026. The filing says Mr. Diaz has no arrangements or understandings with any other person related to his election and no relationships or related transactions requiring disclosure under Item 404(a) of Regulation S-K.

Key details

• Election announced Oct 13, 2026; effective Nov 1, 2026.
• Appointed to the Audit Committee and the Research Committee.
• Compensation will follow the company’s non-employee director practices described in the definitive proxy filed Apr 8, 2026.
• The filing states no arrangements or related transactions requiring Item 404(a) disclosure.

Why it may matter This 8-K reports Item 5.02 (departure of directors or certain officers; election of directors), which covers the appointment of a new director and related disclosures. This filing does not show why the insider traded or why the company acted.